CHIVAX-GD
Dead / Abandoned — Abandoned — failure to respond (as of 23 Aug 2021)
What this means for you
This application is over — abandoned 10 Aug 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88512576
- Mark type
- Stylized text
- Filed
- 12 Jul 2019
- Published for opposition
- 28 Apr 2020
- Abandoned
- 10 Aug 2021
- Attorney of record
- Kevin M. Bovard
Goods and services
- Class 042 — Scientific and technological services: Research and development of vaccines and medicines, namely, the development of vaccine platform technologies; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines, namely, research, development, engineering and testing services focused on vaccine platform technologies; scientific research in the field of vacciness, namely, research and development of cell preparations, cellular vaccines, and therapeutics for the treatment of cancer and infectious diseases; research and development of technology in the field of immunotherapy platforms for manufacturing t-cell based therapeutics for cancer and infectious diseases
Owner
- Virion Therapeutics, LLC, Newark, DE, US
- Virion Therapeutics, LLC, Newark, DE, US
Prosecution history
- 07 Feb 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Feb 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Feb 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Feb 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Feb 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Aug 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 23 Aug 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 08 Feb 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Feb 2021 — NON-FINAL ACTION E-MAILED
- 08 Feb 2021 — SU - NON-FINAL ACTION - WRITTEN
- 07 Jan 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Dec 2020 — USE AMENDMENT FILED
- 07 Jan 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Dec 2020 — TEAS STATEMENT OF USE RECEIVED
- 23 Jun 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT